Toxicologist Peter R. Chai, MD, associate professor of emergency medicine, and Jeffrey T. Lai, MD, medical toxicology fellow, explain the difficulty of getting an objective reading on the level of impairment drivers experience after using marijuana.
Deborah C. Molrine, MD, MPH, deputy director of clinical affairs at MassBiologics and professor of pediatrics, told Science that MassBiologics has identified a human monoclonal antibody that neutralizes the toxin produced by diphtheria—an important advance that could replace the current serum-derived antitoxin.
Erik J. Sontheimer, PhD, professor in the RNA Therapeutics Institute, says that the gene editing biology behind CRISPR may be more than a simple bacterial defense mechanism and could play an important role in gene regulation.
Job Dekker, PhD, Howard Hughes Medical Institute Investigator, professor of biochemistry & molecular pharmacology and co-director of the Program in Systems Biology, explains how his groundbreaking work to map the 3D shape of the genome and his research into topologically associating domains is shedding new light on genetics and disease.
Peter D. Friedmann, MD, MPH, DFASAM, FACP, professor of quantitative health sciences, comments on the rise of fentanyl-related seizures and overdose deaths.
Chancellor Michael F. Collins and Andrew W. Artenstein, MD, regional executive dean, discuss the Population-based Urban and Rural Community Health program UMMS is opening at Baystate Health and the expansion of the UMMS medical class.
Jerry H. Gurwitz, MD, the Dr. John Meyers Professor of Primary Care Medicine and professor of medicine and family medicine & community health, said that recognizing a medication’s side effects can help patients avoid “prescribing cascade.” This happens when, instead of stopping the drug that is causing the problem, a physician prescribes yet another medication to treat the side effect — which can lead to additional side effects or interactions.
Barry G. Saver, MD, MPH, professor of family medicine & community health, evaluated novel decision aids designed to help patients trust and accept controversial, evidence-based U.S. Preventive Services Task Force recommendations about prostate cancer and mammography screening.
Stephen Martin, MD, associate professor of family medicine & community health, comments for story about how restricting opioid prescribing is harming some patients suffering from chronic pain and that deepening doctor-patient conversations about managing pain and seeking alternative treatments need to happen more often.